Loading clinical trials...
Loading clinical trials...
Using a Docudrama Intervention to Increase Repeat Donation Among First-time Blood Donors in Ghana: a Pilot Cluster Randomized, Pragmatic Type 1 Effectiveness- Implementation Hybrid Trial
A cluster pilot RCT to evaluate the effectiveness of the docudrama compared to a control group (usual engagement with blood services) on repeat blood donation attempts among first-time blood donors. Secondary outcomes will be blood donor retention, attitudes, subjective norms, perceived behavioral control and intention as potential mediators of blood donation behavior among first-time blood donors. The cluster pilot RCT will have two arms: 1) docudrama and 2) control. Randomization will stratify by the type of site: mobile versus fixed. Each participant in the docudrama arm will receive the intervention one time immediately after blood donation. Participants in both the docudrama arm and control arm will receive standard blood donor communications and will be followed for six months. Actualized blood donation is possible every four months using NBSG guidelines; however, blood donation sessions may not occur at the blood donation sites until six months. Return blood donation attempts will be evaluated using the Southern Zonal Blood Center (SZBC) records (primary outcome) and participant self-report (secondary outcome) at six months. Secondary measures will be evaluated at baseline and six months from enrollment. The duration of the study will be 11 months, allowing for five months to achieve enrollment goals and six months of follow-up for the last individual enrolled.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Southern Zonal Blood Centre, National Blood Service Ghana
Accra, Ghana
Start Date
August 11, 2025
Primary Completion Date
August 1, 2026
Completion Date
August 1, 2026
Last Updated
September 23, 2025
180
ESTIMATED participants
Docudrama
BEHAVIORAL
Control
BEHAVIORAL
Lead Sponsor
University of Minnesota
Collaborators
NCT06809010
NCT00552214
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT01555060